Regulatory Alert: The Legal Status of BPC 157 in Compounding and Clinical Practice Holt Law Injectable Peptides: Out of the Back Alley and Into the Light? Berkley Lifesciences The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York FDA to weigh easing limits on unproven peptides favored by RFK Jr. and MAHA supporters PBS News FDA to weigh easing limits on peptides promoted by RFK Jr. NBC 6 South Florida